Neurothekeoma Versus Melanoma

Fig. 12.1
Age distribution for 302 patients with neurothekeoma (compiled from [9, 14])


Fig. 12.2
Neurothekeoma, shown here as a well-defined, red-pink nodule. The unusually prominent, arborizing vasculature seen beneath the surface in this case led to a clinical impression of basal cell carcinoma. Original figure from Aydingoz IE, Mansur AT, Dikicioglu-Cetin E. Arborizing vessels under dermoscopy: a case of cellular neurothekeoma instead of basal cell carcinoma. Dermatol Online J. 2013;19(3):5. Retrieved from: ​escholarship.​org/​uc/​item/​1nx5r21x. ©2013 Dermatology Online Journal. Reproduced with permission

Prognosis or Course

No reported case of neurothekeoma has metastasized, and there is only a small risk of recurrence or regrowth associated with incomplete excision (15 % at most) [9, 14]. Therefore, complete excision is the cornerstone of therapy. Location in the head and neck is also correlated with higher recurrence risk, likely reflecting more conservative excisions. There are no established histopathologic features that predict recurrence (see below) [9, 14].


Neurothekeoma is a tumor of uncertain origin and unclear differentiation. Based on light microscopy, immunohistochemistry, and ultrastructural examination, various lines of differentiation have been proposed, including (myo)fibroblastic (fibro)histiocytic, and neuroectodermal [9, 2023]. Microarray data comparing DNSM with neurothekeoma revealed that not only do the two tumors demonstrate divergent expression profiles, but DNSM clustered with schwannoma, while neurothekeoma clustered with cellular fibrous histiocytoma [24]. However, this study utilized a limited number and range of cases, so further investigation is necessary.


Microscopic examination discloses a multinodular, variably circumscribed mass in the dermis and/or subcutis (Fig. 12.3a). The epidermis is not directly involved by tumor but may be atrophic, and a Grenz zone is often seen (Fig. 12.3b) [14, 15, 25]. The mass is composed of whorled nests and bundles of cells (Fig. 12.3c). The whorled, concentric arrangements of cells have been deemed neuroid characteristics and likened to endoneuriallike structures [15]. The constituent cells range from epithelioid to spindled, with abundant, faintly eosinophilic cytoplasm and indistinct cell borders (Fig. 12.3d). Fetsch et al. [9] noted a somewhat granular quality to the cytoplasm. Nuclei are usually ovoid with fine chromatin and indistinct nucleoli. Dense collagen bands often separate the cellular nests and bundles (Fig. 12.3e). For cases exhibiting florid stromal sclerosis, the term “desmoplastic cellular neurothekeoma” has been endorsed by some authors [18, 25, 26]. Myxoid matrix is variably present in neurothekeoma (Fig. 12.3f), accounting for much of its morphologic variability, which is delineated in Table 12.1. Osteoclast-like giant cells are present in 15–39 % of cases, and rarely, Touton giant cells are seen [9, 14]. Mitotic activity varies from none to 41 per 10 high-power fields, with an average of 2–3 per 10 high-power fields [9, 14].


Fig. 12.3
Neurothekeoma. (a) Low-power view shows a multinodular, variably circumscribed mass in the dermis and subcutis (H&E, ×1). (b) The epidermis is spared (H&E, ×10). (c) A whorled nest of cells is depicted (H&E, ×40). (d) Cells range from epithelioid to spindled, with abundant, faintly eosinophilic cytoplasm (H&E, ×20). (e) Dense collagen bands may separate the nests of cells (H&E, ×10). (f) Myxoid matrix is apparent in this view (H&E, ×20)

Table 12.1
Morphologic spectrum of neurothekeoma [9, 14]

Morphologic patternsa




Myxoid matrix

≤10 %

>10 % and ≤50 %

>50 %

Focal or absent

Architectural features

Multinodular configuration of whorled nests and bundles, sometimes fascicles

Larger nests

Multinodular, haphazardly arranged fascicles

Cell growth pattern is more random and less whorled/fascicular

Prominent sclerotic, fibrotic background

Dense collagen among the nests and bundles

Dense collagen not as evident

Cytologic features

Shape spindled to epithelioid (most have both)

Cytoplasm abundant and faintly eosinophilic

Cell borders indistinct

Nuclear featuresb

Shape ovoid

Chromatin usually fine

Nucleoli usually inconspicuous or pinpoint

Mitotic figures

Number variable (average 2–3 per 10 HPF, range 0–41 per 10 HPF)

Atypical forms rarely seen (2 % of cases)

Non-lesional cells

Osteoclast-like giant cells in 15–39 % of cases

Occasional dendritic cells, mast cells

5 % of cases have Touton or tumor giant cells

Melanocytic lesions in the differential diagnosis

Spitz nevus (amelanotic intradermal)

Myxoid melanoma

Desmoplastic melanoma or nevi

Melanoma (metastatic or primary intradermal)

Nevus (amelanotic intradermal)

aThere is no established clinical significance to subdividing neurothekeomas; rather, the significance lies in illustrating patterns and their corresponding differential diagnoses

bMost cases demonstrate minimal nuclear atypia, with a minority (12–25 %) showing focal or scattered atypical cells with enlarged nuclei, coarse chromatin, and prominent nucleoli

Overall, most neurothekeomas have a banal appearance, but atypical features are well documented [9, 14, 21, 27]. A minority of cases (12–25 %) exhibit focal or scattered atypical cells with enlarged nuclei, coarse chromatin, and prominent nucleoli [9, 14], including tumor giant cells in 5 % of cases [14]. Other atypical features, such as tumor size >2 cm, high mitotic rate, atypical mitotic figures, and infiltration of fat or skeletal muscle, are seemingly insignificant with respect to biologic behavior [9, 14, 25, 27]. Vascular and perineural invasion have been described [21, 27, 28]. Necrosis is exceptional [14]. Other unusual features in neurothekeoma include collagen trapping, hemorrhage, lymphocytic cuffing, chondroid stroma, and cellular vacuolization. In rare cases exhibiting sheet-like growth, there is at least focal nesting of epithelioid and spindled cells characteristic of neurothekeoma [21]. Extensive calcification and even ossification have been reported [29, 30].


The immunophenotype of neurothekeoma is nonspecific but fairly consistent (Fig. 12.4) and thus can be supportive of the microscopic impression. S100 protein and GFAP are almost always negative [9, 10, 14], with few reports of focal S100 positivity [16], supporting the argument that it is distinct from DNSM and is not a nerve sheath tumor. Care must be taken to distinguish lesional from non-lesional cells, as S100-positive dendritic cells may be peppered throughout the tumor (Fig. 12.5) [9]. Other markers that are consistently negative in neurothekeoma include Melan-A, tyrosinase, neurofilament, CD34, desmin, and cytokeratins. gp100 (HMB-45) is usually negative, but rare cases demonstrate minimal expression [9].


Fig. 12.4
Immunophenotype of neurothekeoma, compiled from the two largest series to date [9, 14]. *Based on only 10 cases. **Focally or diffusely positive. †A single case demonstrated focal desmin positivity. ‡Mostly diffuse positivity


Fig. 12.5
(a) The lesional cells are negative for S100, but scattered S100-positive dendritic cells are noted (×20). (b) Strong CD10 expression, although not specific, is consistently seen (×10)

Notwithstanding the consistent S100 negativity in lesional cells, the frequent expression of MITF, NK1/C3, PGP9.5, and NSE has led several authors to propose a neuroectodermal origin for neurothekeoma [19, 23, 27, 31, 32]. However, this suggestion has been heavily criticized on the basis of the restricted specificities and sensitivities of these markers. For example, MITF expression was observed in over 80 % of neurothekeomas in two large series [9, 14], but a smaller subsequent study reported focal or no expression in most of their cases [33]. MITF also suffers from questionable specificity, with expression reported in many reactive and neoplastic cells of non-neuroectodermal origin [3436]. Similarly, NK1/C3 expression has been reported in a wide array of neoplasms of many lineages aside from melanocytic, including (fibro)histiocytic tumors [37]. PGP9.5 was originally reported as a marker for neurothekeoma based on a study of 12 cases [32], but its promiscuity was later exposed in a report of strong expression in the vast majority of non-neuroectodermal and neuroectodermal neoplasms [38]. Two studies endorse S100A63 as a more sensitive alternative to PGP9.5 but report a similar poor specificity [16, 31]. Finally, SOX-10, a marker of neuroectodermal differentiation, has been reported as negative in all of 25 neurothekeomas in one series [33]. Therefore, the notion of a neuroectodermal origin for neurothekeoma seems tenuous at best.

Genetic and Molecular Findings

As mentioned previously, microarray analysis revealed disparate expression profiles for neurothekeoma and DNSM, with the former resembling cellular fibrous histiocytoma and the latter resembling dermal schwannoma [24]. No recurring chromosomal abnormalities have been described for neurothekeoma.

Differential Diagnosis: Non-melanocytic Lesions

The most common alternative diagnoses rendered by pathologists for neurothekeoma cases include melanocytic lesions, neural tumors, fibrohistiocytic proliferations, and DNSM (Fig. 12.6) [9, 14], each of which can present as an amelanotic dermal proliferation of epithelioid or spindled cells [15]. The salient discriminatory features for neurothekeoma versus non-melanocytic lesions are reviewed in Table 12.2. Of special note is that neurothekeoma and plexiform fibrohistiocytic tumor are best distinguished on morphologic grounds, as no immunohistochemical marker can distinguish the two with certainty [14, 16, 39]. The distinction is important, as plexiform fibrohistiocytic tumor has some metastatic potential [6]. Other non-melanocytic lesions entering into the differential for neurothekeoma include reticulohistiocytoma and variants of fibrous histiocytoma [9]. Architectural features, such as a lack of whorled growth in reticulohistocytoma or the presence of storiform growth in fibrous histiocytoma, can lead to the correct diagnosis without a need for ancillary studies. Another diagnosis that may be considered is a pilar leiomyoma [40] in cases expressing smooth-muscle actin (SMA). Although neurothekeomas contain spindle cells with eosinophilic cytoplasm, they lack the characteristic cigar-shaped or corkscrew nuclei of smooth-muscle tumors. Desmin expression can exclude neurothekeoma. Likewise, S100 positivity can exclude neurothekeoma, which resolves the neuronal and Schwannian differentials.


Fig. 12.6
Frequencies of alternative diagnoses for cases of neurothekeoma offered by contributing pathologists in the largest series to date [9]. A malignant diagnosis was considered in 21 % of cases. Diagnoses within the “Other” category include granulomatous processes, skin adnexal tumors, smooth-muscle tumors, granular cell tumors, and various sarcomas

Table 12.2
The non-melanocytic differential diagnosis of neurothekeoma [6, 9, 10, 14]


Dermal nerve sheath myxoma (DNSM)

Plexiform fibrohistiocytic tumor

Superficial angiomyxoma (cutaneous myxoma)

Clinical features

Young women > men

Young to middle-aged adults

Children and young adults

Sporadic or associated with Carney’s

Head and neck, especially the face

Distal extremities

Upper extremities, especially the forearm

Trunk, legs, head and neck (eyelids in Carney’s)

Benign; low recurrence rate (<15 %) when incompletely excised

Benign; high local recurrence rate (up to 50 %) when incompletely excised

Metastatic potential; 13–38 % local recurrence rate

Benign, but local recurrence is common (up to 40 %)

Cellular architecture

Poorly marginated, multinodular mass of whorled nests and bundles, sometimes fascicles

Multilobulated mass of sharply demarcated lobules with highly myxoid matrix

Multinodular mass composed of nodules of histiocyte-like cells and fascicles of spindle cells in varying proportions (fascicles usually longer and better defined compared to neurothekeoma)

Multinodular, myxoid, paucicellular mass with variable dermarcation

Prominent peripheral fibrous border

Cleft-like spaces at the interface of the nodule and surrounding tissue

Variable myxoid matrix (architecture is more random with more myxoid matrix)

Myxoid stromal change can be seen but is not prominent

Wispy collagen fibers throughout the stroma

Delicate vasculature

Dense collagen among the nests and bundles

Cellular morphology

Shape is spindled to epithelioid

Shape is spindled, stellate, ring-shaped (resembling adipocytes), or epithelioid (often forming cords and syncytial aggregates)

The spindled cells are (myo)fibroblastic in appearance

Shape is spindled or stellate

The histiocyte-like cells may appear epithelioid

Mononuclear or multinucleated

Cytoplasm is abundant and faintly eosinophilic

Less nuclear variability than that seen in neurothekeoma

Nuclear chromatin often “smudgy”

Cell borders are indistinct

Cytoplasmic-nuclear invaginations common

Osteoclast-like giant cells





Immunohistochemical differences

:S100 –, GFAP –, CD34 –

S100 +, GFAP +

No clear distinguishing markers

S100 –, CD34 –

Differential Diagnosis: Melanocytic Lesions

The broad morphologic spectrum of neurothekeoma notoriously overlaps with that of various melanocytic lesions. Although most neurothekeomas have a banal microscopic appearance, a wide range of mitotic activity and cytologic atypia can be seen, permitting consideration of benign and malignant melanocytic lesions alike. As reviewed in Table 12.1, each morphological pattern of neurothekeoma corresponds to its own group of melanocytic entities. Neurothekeomas with the more cellular patterns, owing to their nests or “theques” of spindled to epithelioid cells, overlap with intradermal nevi, Spitz tumors, and melanomas. The so-called desmoplastic cellular pattern of neurothekeoma can be confused with desmoplastic melanoma [18, 25, 26]. In cases of neurothekeoma with prominent myxoid matrix, myxoid melanoma may be considered [4147]. The distinguishing clinicopathologic features of each are discussed below. In any case, the most invaluable distinguishing tool for neurothekeoma versus any melanocytic lesion (aside from careful microscopic scrutiny) is S100 immunohistochemistry. A lack of S100 expression is a hallmark of neurothekeoma, whereas nearly all melanocytic lesions express S100 [41]. Distinguishing neurothekeoma from any malignant melanocytic lesion is of paramount importance, as the clinical ramifications can be drastic.

Neurothekeoma vs. Intradermal Spitz Nevus

In the largest neurothekeoma series to date [9], Spitz nevus was the most commonly considered melanocytic entity in the differential. Neurothekeoma—namely, the cellular pattern—overlaps significantly with amelanotic, intradermal Spitz nevi, both clinically and morphologically. Both affect predominantly young patients (Fig. 12.7) with a female preponderance. The amelanotic Spitz nevus also exhibits a proclivity for the head and neck, where it typically presents as a dome-shaped, red-to-pink papule or nodule [48]. Intradermal Spitz accounts for up to 20 % of Spitz lesions [49]. Histologically, the epidermal changes associated with Spitz nevi tend to be hyperplastic [5052], which is not a usual feature of neurothekeoma [9, 14, 15]. The overall multinodular shape of neurothekeoma contrasts with the classic wedge shape of Spitz nevi [50]. Although both lesions contain spindled to epithelioid cells in a collagenous stroma, only Spitz nevi show maturation. Additionally, the cellular whorling that is characteristic of neurothekeoma is not a feature of Spitz nevi [15]. Myxoid matrix, if present, steers toward the interpretation of neurothekeoma, as it is very rare in Spitz nevi [53, 54]. Although both lesions can have giant cells, those of neurothekeoma are described as osteoclastic, which are not described in Spitz nevi [49, 51, 52]. The lesions are compared in Table 12.3 and Fig. 12.8.
Oct 29, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Neurothekeoma Versus Melanoma
Premium Wordpress Themes by UFO Themes
%d bloggers like this: